When was Sonovascular founded?

Sonovascular was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is Sonovascular located?

Sonovascular is headquartered in Chapel Hill, United States.

Who is the current CEO of Sonovascular?

Daniel Estay of Sonovascular. They have also founded 1 company.

How many employees does Sonovascular have?

As of Jul 31, 2026, the latest employee count at Sonovascular is 12.

Is Sonovascular a funded company?

Sonovascular is a funded company, having raised a total of $6M across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 15, 2020.

When was the latest funding round of Sonovascular?

Sonovascular's latest funding was a $***** Series A round on Feb 03, 2026, with participation from 1 investor.

Where does Sonovascular rank among its competitors?

Sonovascular ranks 7th amongst 128 active competitors, of which 36 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Thrombolex, which secured $50M in Feb, 2026.

Who are the top competitors of Sonovascular?

Sonovascular's top competitors include SMT, Thrombolex and Terumo Medical. Among them, Thrombolex secured the most recent funding round in February, 2026.

Sonovascular - 2026 Company Profile, Team, Funding & Competitors

Sonovascular is a series A company based in Chapel Hill (United States), founded in 2017 by Daniel Estay. It operates as an eveloper of a medical device to treat arterial and venous diseases. Sonovascular has raised $6M in funding from NC State University and Harbright Ventures. The company has 128 active competitors, including 36 funded and 34 that have exited. Its top competitors include companies like SMT, Thrombolex and Terumo Medical.

Company Details

Developer of a medical device to treat arterial and venous diseases. It offers multi-mechanism thrombectomy system for the endovascular treatment of diseases which include deep vein thrombosis, pulmonary embolism, peripheral artery occlusion, and acute ischemic stroke.

Website: sonovascular.com
Email ID: *****@sonovascular.com

Key Metrics

Founded Year

2017

Location

Chapel Hill, United States

Stage

Series A

Total Funding

$6M in 4 rounds

Latest Funding Round

Series A, Feb 03, 2026, $*****

Investors

NC State University & 2 more

Ranked

7^th among 128 active competitors

Employee Count

12 as on Jul 31, 2026

Similar Companies

SMT & 163 more

View Sonovascular's full profile

Sonovascular is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SonoVascular, Inc. CIN: 861957269 , United States, Active		-	-	-

Sonovascular has raised a total funding of $6M over 4 rounds. Its first funding round was on Aug 15, 2020. Its latest funding round was a Series A round on Feb 03, 2026 for $*****. 1 investor participated in its latest round. Sonovascular has 3 institutional investors.

Here is the list of recent funding rounds of Sonovascular:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 03, 2026	7321912	Series A	9959822	3662821	3919370	9344736
Jul 12, 2023	2441107	Seed	3330455	5904991	8193439	4028631
Jan 17, 2023	1010195	Conventional Debt	6360516	6703238	3797007	4332814

Access funding benchmarks and valuations. Sign up today!

View details of Sonovascular's funding rounds and investors

The founders of Sonovascular is Daniel Estay. Daniel Estay is the CEO of Sonovascular.

Here are the details of Sonovascular's key team members:

Daniel Estay: Founder & CEO of Sonovascular.
Contact Info: 1 email address

View details of Sonovascular's Founder profiles and Board Members

Sonovascular's employee count trend

Sonovascular has 12 employees as of Jul 26. Here is Sonovascular's employee count trend over the years:

Uncover Sonovascular's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sonovascular include SMT, Thrombolex and Terumo Medical. Here is the list of Top 10 competitors of Sonovascular, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SMT 1998, Surat (India), Late Stage	Manufacturer of minimally invasive cardiovascular devices including coronary and structural heart	$93.5M	Samara Capital, Kotak Mahindra Bank & 105 others	71/100
2nd	Thrombolex 2016, Doylestown (United States), Series A	Developer of endovascular catheters for acute venous thromboembolic conditions	$67.8M	Orbimed, HHS	54/100
3rd	Terumo Medical 1921, Shibuya (Japan), Funding Raised	Provider of a portfolio of medical devices for interventional cardiology	-	USAGov, BCM Technologies	52/100
4th	Vascular Solutions 1997, Minneapolis (United States), Acquired	Products for vascular diagnostics and interventional procedures	$12M	SpringRock Ventures, Stephens & 3 others	52/100
5th	iHeart 2013, Kyoto (Japan), Series D	Experts in regenerative medicine	$5.44M	Japan Asia Investment, Miyako Capital & 5 others	51/100
6th	Cardiovascular Systems 1989, Saint Paul (United States), Acquired	Developer of devices for treating peripheral and coronary vascular disease	$121M	Maverick Ventures, Mitsui Global Investment ... & 6 others	50/100
7th	Sonovascular 2017, Chapel Hill (United States), Series A	eveloper of a medical device to treat arterial and venous diseases	$6M	NIH, NC State University & 1 others	50/100
8th	Contego Medical 2005, Raleigh (United States), Series D	Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature	$66M	Hatteras Venture Partners, Tidewater Investment Company ... & 7 others	49/100
9th	Echopoint Medical 2018, London (United Kingdom), Series A	Developer of smart devices for monitoring coronary artery disease and microvascular dysfunction	$9.99M	UCL Technology Fund, Parkwalk & 3 others	47/100
10th	Limflow 2012, Paris (France), Acquired	Developer a system for venous arterialization of the lower limbs	$97.5M	Longitude Capital, Sofinnova Partners & 6 others	47/100